Hepatitis C, like hepatitis B, is an infectious hepatitis, mainly through blood, sex life, and vertical transmission from mother to child. Unfortunately, the medical community has not yet developed an effective vaccine against hepatitis C. Because hepatitis C virus is an RNA virus, it is easy to mutate, and it is very difficult to develop a vaccine. Because other animals except humans and chimpanzees do not suffer from hepatitis C, it is difficult to find an animal model for vaccine development. Therefore, early detection, early diagnosis, and early treatment is particularly important.

Signal Biotech applies a unique freeze-drying technology to develop a freeze-dried real-time RT-PCR reagent for detection of hepatitis C virus. This product does not require cold-chain for storage and shipping, and is predispensed into individual PCR tubes for easy use, thus effectively reduce cost associated with shipping and losses due to cold-chain failure, repeated freezing and thawing, pipetting errors, and arosul contamination. It is ideal for distribution for international markets and to regins with limited cold-chain resources. 

Hepatitis C virus

• Hepatitis C virus
• real-time PCR
• freeze-dried
• detection
• nuclei acid amplification test
• NAAT